Jump to content

Prednicarbate: Difference between revisions

Page 1
Page 2
Content deleted Content added
CheMoBot (talk | contribs)
Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref') per Chem/Drugbox validation (report errors or [[user talk:CheMoBot
 
(34 intermediate revisions by 18 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{drugbox
{{Drugbox
| verifiedrevid = 379587793
| Verifiedfields = changed
| IUPAC_name = (11β)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3,20-dioxopregna-1,4-dien-21-yl propionate
| Watchedfields = changed
|synonyms = <small>[2-[(8''S'',9''S'',10''R'',11''S'',13''S'',14''S'',17''R'')-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6''H''-cyclopenta[''a'']phenanthren-17-yl]-2-oxoethyl] propanoate</small>
| verifiedrevid = 396722627
| IUPAC_name = 17-[(Ethoxycarbonyl)oxy]-11β-hydroxy-3,20-dioxopregna-1,4-dien-21-yl propionate
| image = Prednicarbate.png
| image = Prednicarbate.png
| width = 250px
| CASNo_Ref = {{cascite}}

| CAS_number = 73771-04-7
<!--Clinical data-->
| ATC_prefix = D07
| ATC_suffix = AC18
| tradename =
| Drugs.com = {{drugs.com|monograph|prednicarbate}}
| ATC_supplemental =
| PubChem = 6714002
| MedlinePlus = a604021
| DrugBank = APRD01197
| C=27 | H=36 | O=8
| molecular_weight = 488.57 g/mol
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| legal_US = <!-- OTC / Rx-only -->
| legal_status =
| legal_status =
| routes_of_administration = [[Topical]]
| routes_of_administration = [[Topical]]
<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
<!--Identifiers-->
| IUPHAR_ligand = 7605
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 73771-04-7
| ATC_prefix = D07
| ATC_suffix = AC18
| ATC_supplemental =
| PubChem = 6714002
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB01130
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = V901LV1K7D
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1200386
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 5145991
| smiles = O=C(OCC(=O)[C@@]1(OC(=O)OCC)CC[C@H]2[C@H]4[C@H]([C@@H](O)C[C@]12C)[C@]/3(/C=C\C(=O)\C=C\3CC4)C)CC
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C27H36O8/c1-5-22(31)34-15-21(30)27(35-24(32)33-6-2)12-10-19-18-8-7-16-13-17(28)9-11-25(16,3)23(18)20(29)14-26(19,27)4/h9,11,13,18-20,23,29H,5-8,10,12,14-15H2,1-4H3/t18-,19-,20-,23+,25-,26-,27-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = FNPXMHRZILFCKX-KAJVQRHHSA-N
<!--Chemical data-->
| C=27 | H=36 | O=8
| synonyms = <small>{2-[(8''S'',9''S'',10''R'',11''S'',13''S'',14''S'',17''R'')-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6''H''-cyclopenta[''a'']phenanthren-17-yl]-2-oxoethyl} propanoate</small>
}}
}}


'''Prednicarbate''' is a relatively new [[topical]] [[corticosteroid]] drug. It is similar in potency to [[hydrocortisone]]. Compared to other topical corticosteroids, like [[betamethasone]], repeated prednicarbate use does not cause [[skin]] [[atrophy]] as quickly.{{Fact|date=September 2008}} Corticosteroids have always been an important part of the pharmacological arsenal of [[dermatology]]; however, their tendency to produce side-effects has caused the need to search for new preparations.
'''Prednicarbate''' is a relatively new [[topical]] [[corticosteroid]] drug. It is similar in potency to [[hydrocortisone]]. Corticosteroids have always been an important part of the pharmacological arsenal of [[dermatology]]; however, their tendency to produce side-effects has caused the need to search for new preparations.<ref>{{cite book|url=https://books.google.com/books?id=4-MjAQAAMAAJ|title=United States Pharmacopeia, the National Formulary|publisher=United States Pharmacopeial Convention, Incorporated|year=2008|isbn=978-1-889788-53-1|page=3060}}</ref>


It is nonhalogenated.<ref name="pmid15657633">{{cite journal |author=Gupta AK, Chow M |title=A review of prednicarbate (Dermatop) |journal=Skin Therapy Lett. |volume=9 |issue=10 |pages=5–6, 9 |year=2004 |pmid=15657633 |doi= |url=http://www.skintherapyletter.com/2004/9.10/2.html}}</ref>
It is nonhalogenated.<ref name="pmid15657633">{{cite journal |vauthors=Gupta AK, Chow M |title=A review of prednicarbate (Dermatop) |journal=Skin Therapy Lett. |volume=9 |issue=10 |pages=5–6, 9 |year=2004 |pmid=15657633 |url=http://www.skintherapyletter.com/2004/9.10/2.html}}</ref>


==References==
==References==
<references />
{{reflist}}
{{Glucocorticoids}}

{{Glucocorticoidics}}
{{Corticosteroids}}


[[Category:Corticosteroid esters]]
[[Category:Corticosteroids]]
[[Category:Corticosteroids]]
[[Category:Propionates]]
[[Category:Propionate esters]]
[[Category:Carbonate esters]]
[[Category:Carbonate esters]]
[[Category:Ethyl esters]]




{{dermatologic-drug-stub}}
{{dermatologic-drug-stub}}

[[ru:Предникарбат]]
[[uk:Преднікарбат]]